CG Oncology Inc. CGON 深 沪
等待开盘 08-04 09:30:00 美东时间
26.31
-0.380
-1.42%
华盛通- 最 高26.63
- 今 开26.06
- 成交量 81.55万股
- 最 低 25.73
- 昨 收 26.69
- 总市值 20.05亿
- 52周最高 40.47
- 市盈率 静 --
- 换手率 1.07%
- 52周最低 14.80
- 委 比 86.69%
- 总股本 7622.53万
- 历史最高 50.23
- 量 比 0.80
- 振 幅 3.37%
- 历史最低 14.80
- 每 手 1
- 风险率 5.23%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Delaware Court Gives Unanimous Verdict Detailing That CG Oncology Will Owe No Future Royalties Or Other Payments To ANI Pharmaceuticals
CG Oncology, Inc. (NASDAQ:CGON), a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients with bladder cancer, today
07-30 04:24
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Medpace Hldgs (NASDAQ:MEDP) shares moved upwards by 44.6% to $446.6 du...
07-22 20:07
Beyond The Numbers: 7 Analysts Discuss CG Oncology Stock
Across the recent three months, 7 analysts have shared their insights on CG Onc...
07-17 05:03
大摩力荐CG Oncology(CGON.US) 其膀胱癌疗法具有显著优势
摩根士丹利将制药公司CG Oncology(CGON.US)的目标价从52美元上调至56美元，同时维持“增持”评级。
07-07 14:24
美股大行评级 | 潜在涨幅40%！华兴资本首予Coinbase买入评级，目标价353.3！Sarepta治疗遭多家机构下调评级和目标价！
美股大行评级 | 潜在涨幅40%！华兴资本首予Coinbase买入评级，目标价353.3！Sarepta治疗遭多家机构下调评级和目标价！
06-18 09:46
Morgan Stanley Maintains Overweight on CG Oncology, Raises Price Target to $56
Morgan Stanley analyst Jeffrey Hung maintains CG Oncology (NASDAQ:CGON) with a Overweight and raises the price target from $52 to $56.
06-17 23:02
CG Oncology to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
CG Oncology的CEO Arthur Kuan将参加6月10日在迈阿密海滩举行的Goldman Sachs全球医疗保健会议，并在会上进行炉边谈话。活动直播可通过公司官网获取，回放可供观看90天。CG Oncology致力于研发膀胱癌免疫疗法，改善患者生活质量。如需更多信息，请访问官网或联系媒体或投资者关系。
06-05 12:00
Morgan Stanley Maintains Overweight on CG Oncology, Lowers Price Target to $52
Morgan Stanley analyst Jeffrey Hung maintains CG Oncology (NASDAQ:CGON) with a Overweight and lowers the price target from $55 to $52.
05-19 22:33
CG Oncology, Inc. GAAP EPS of $0.45
CG Oncology, Inc. press release (NASDAQ:CGON): Q1 GAAP EPS of $0.45. Cash and cash equivalents and marketable securities as of March 31, 2025, were $688.4M, compared with $742M as of December 31, 2024...
05-14 02:54
